BIONANO GENOMICS INC's ticker is BNGO and the CUSIP is 09075F107. A total of 160 filers reported holding BIONANO GENOMICS INC in Q1 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $351,898 | -88.0% | 576,883 | -78.1% | 0.00% | -100.0% |
| Q1 2023 | $2,929,223 | -26.9% | 2,638,940 | -3.8% | 0.00% | 0.0% |
| Q4 2022 | $4,005,858 | -17.0% | 2,743,738 | +4.0% | 0.00% | 0.0% |
| Q3 2022 | $4,829,000 | +33.1% | 2,639,011 | +0.3% | 0.00% | 0.0% |
| Q2 2022 | $3,629,000 | -49.1% | 2,629,841 | -4.8% | 0.00% | 0.0% |
| Q1 2022 | $7,130,000 | -15.9% | 2,763,319 | -2.6% | 0.00% | 0.0% |
| Q4 2021 | $8,482,000 | -43.9% | 2,837,141 | +3.1% | 0.00% | -66.7% |
| Q3 2021 | $15,132,000 | +84.0% | 2,751,339 | +145.2% | 0.00% | +200.0% |
| Q2 2021 | $8,222,000 | +186.0% | 1,121,889 | +215.3% | 0.00% | 0.0% |
| Q1 2021 | $2,875,000 | +224.1% | 355,780 | +23.6% | 0.00% | – |
| Q4 2020 | $887,000 | +853.8% | 287,892 | +102.3% | 0.00% | – |
| Q3 2020 | $93,000 | +190.6% | 142,343 | +129.7% | 0.00% | – |
| Q2 2020 | $32,000 | +190.9% | 61,963 | +146.1% | 0.00% | – |
| Q1 2020 | $11,000 | -35.3% | 25,179 | +82.7% | 0.00% | – |
| Q4 2019 | $17,000 | – | 13,784 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Inspire Advisors, LLC | 368,943 | $952,000 | 0.27% |
| QCM Cayman, Ltd. | 10,568 | $27,000 | 0.12% |
| CPR Investments Inc. | 29,687 | $77,000 | 0.06% |
| Cutter & CO Brokerage, Inc. | 62,700 | $162,000 | 0.05% |
| Kalos Management, Inc. | 26,620 | $68,000 | 0.05% |
| Archford Capital Strategies, LLC | 79,483 | $206,000 | 0.05% |
| Platform Technology Partners | 31,450 | $81,000 | 0.04% |
| CIM INVESTMENT MANAGEMENT INC | 26,657 | $69,000 | 0.02% |
| Bank Julius Baer & Co. Ltd, Zurich | 1,396,938 | $3,604,000 | 0.02% |
| Golden State Equity Partners | 17,037 | $44,000 | 0.02% |